Eli Lilly’s Antibody Trial Is Paused Over Potential Safety Concern. Clinical Trials, Drugs (Pharmaceuticals), Coronavirus (2019-nCoV), Eli Lilly and Company, Johnson & Johnson, AstraZeneca PLC, your-feed-healthcare